Literature DB >> 19591123

MicroRNA-122 might be a double-edged sword in hepatocellular carcinoma.

Rui Zhang, Lei Wang, Gui-Rong Yu, Xiang Zhang, Li-Bo Yao, An-Gang Yang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19591123     DOI： 10.1002/hep.23108

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  4 in total

Review 1.  The role of microRNAs in human liver cancers.

Authors:  Chiara Braconi; Jon C Henry; Takayuki Kogure; Thomas Schmittgen; Tushar Patel
Journal:  Semin Oncol       Date:  2011-12       Impact factor: 4.929

Review 2.  Promises and challenges of MicroRNA-based treatment of multiple myeloma.

Authors:  P Tagliaferri; M Rossi; M T Di Martino; N Amodio; E Leone; A Gulla; A Neri; P Tassone
Journal:  Curr Cancer Drug Targets       Date:  2012-09       Impact factor: 3.428

Review 3.  The role of microRNAs in liver cancer progression.

Authors:  S Huang; X He
Journal:  Br J Cancer       Date:  2010-11-23       Impact factor: 7.640

4.  miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.

Authors:  Ming Chen; Wei Hu; Chen-Ling Xiong; Zhen Qu; Chang-Qing Yin; Yu-Hui Wang; Chang-Liang Luo; Qing Guan; Chun-Hui Yuan; Fu-Bing Wang
Journal:  Oncotarget       Date:  2016-12-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.